• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤大小对典型肺类癌淋巴结受累情况的影响

The Impact of Tumor Size on Node Involvement in Typical Lung Carcinoids.

作者信息

Elliott Irmina A, Liou Douglas Z, Lui Natalie S, Backhus Leah M, Shrager Joseph B, Myall Nathaniel, Berry Mark F

机构信息

Division of Thoracic Surgery, Department of Cardiothoracic Surgery, Stanford University, Stanford, California.

Veterans Affairs Palo Alto Health Care System, Palo Alto, California.

出版信息

Ann Thorac Surg Short Rep. 2023 Aug 22;1(4):543-547. doi: 10.1016/j.atssr.2023.07.016. eCollection 2023 Dec.

DOI:10.1016/j.atssr.2023.07.016
PMID:39790680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11708276/
Abstract

BACKGROUND

Observation has been suggested as an alternative to surgical resection for small typical lung carcinoids. We sought to evaluate the potential impact of tumor growth and lymphatic spread during observation by examining predictors of node positivity and the impact of tumor size and node status on survival.

METHODS

National Cancer Database cases of typical lung carcinoid resections from 2006 to 2016 were analyzed. Predictors of lymph node involvement and survival were determined.

RESULTS

Overall, 1019 of 8257 patients who underwent typical carcinoid resection had at least 1 positive node (12.3%). The incidence of node positivity among the 921 patients with subcentimeter tumors was 5.4% (n = 50). Increasing tumor size was independently associated with nodal involvement. Patients with nodal involvement had significantly worse 5-year survival (89.5% vs 94.0%; < .001). Increasing tumor size was not associated with worse survival in multivariable analysis, but node positivity did independently predict worse survival.

CONCLUSIONS

More than 5% of patients with subcentimeter typical carcinoids of the lung have nodal metastases, and node involvement is an independent predictor of worse survival, whereas tumor size is not. These data suggest that even patients with small tumors should generally undergo resection when diagnosed.

摘要

背景

对于小的典型肺类癌,观察被建议作为手术切除的替代方法。我们试图通过检查淋巴结阳性的预测因素以及肿瘤大小和淋巴结状态对生存的影响,来评估观察期间肿瘤生长和淋巴转移的潜在影响。

方法

分析了国家癌症数据库中2006年至2016年典型肺类癌切除术的病例。确定了淋巴结受累和生存的预测因素。

结果

总体而言,8257例行典型类癌切除术的患者中,1019例至少有1个阳性淋巴结(12.3%)。921例肿瘤直径小于1厘米的患者中,淋巴结阳性发生率为5.4%(n = 50)。肿瘤大小增加与淋巴结受累独立相关。有淋巴结受累的患者5年生存率明显较差(89.5%对94.0%;P <.001)。在多变量分析中,肿瘤大小增加与生存率较差无关,但淋巴结阳性确实独立预测生存率较差。

结论

超过5%的肺典型类癌直径小于1厘米的患者有淋巴结转移,淋巴结受累是生存率较差的独立预测因素,而肿瘤大小不是。这些数据表明,即使是小肿瘤患者在诊断时一般也应接受手术切除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c9/11708276/ca8c22b802db/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c9/11708276/ca8c22b802db/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64c9/11708276/ca8c22b802db/gr1.jpg

相似文献

1
The Impact of Tumor Size on Node Involvement in Typical Lung Carcinoids.肿瘤大小对典型肺类癌淋巴结受累情况的影响
Ann Thorac Surg Short Rep. 2023 Aug 22;1(4):543-547. doi: 10.1016/j.atssr.2023.07.016. eCollection 2023 Dec.
2
Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases.类癌淋巴结转移的发生率和预后意义。
Ann Thorac Surg. 2018 Oct;106(4):981-988. doi: 10.1016/j.athoracsur.2018.05.044. Epub 2018 Jun 15.
3
Examination of factors associated with lymph node metastases in lung carcinoids: Results from a single institution retrospective cohort study.探讨肺类癌淋巴结转移相关因素:单中心回顾性队列研究结果。
Lung Cancer. 2021 Apr;154:186-194. doi: 10.1016/j.lungcan.2021.01.017. Epub 2021 Jan 23.
4
[Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].[肺类癌:单机构经验及预后因素分析]
Acta Med Port. 2014 Nov-Dec;27(6):749-54. Epub 2014 Dec 30.
5
Pulmonary carcinoid tumours: A multi-centre analysis of survival and predictors of outcome following sublobar, lobar, and extended pulmonary resections.肺类癌肿瘤:亚肺叶、肺叶和扩大性肺切除术后生存和预后预测因素的多中心分析。
Asian Cardiovasc Thorac Ann. 2021 Jul;29(6):532-540. doi: 10.1177/02184923211010090. Epub 2021 Apr 14.
6
Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.典型和非典型肺类癌:伴有区域淋巴结受累患者的预后
Chest. 2001 Apr;119(4):1143-50. doi: 10.1378/chest.119.4.1143.
7
Bronchial carcinoid tumors: nodal status and long-term survival after resection.支气管类癌肿瘤:切除术后的淋巴结状态及长期生存情况
Ann Thorac Surg. 2004 May;77(5):1781-5. doi: 10.1016/j.athoracsur.2003.10.089.
8
Lymphadenectomy for lung carcinoids: Which factors may predict nodal upstaging? A multi centric, retrospective study.肺癌类癌的淋巴结清扫术:哪些因素可能预测淋巴结升级?一项多中心、回顾性研究。
J Surg Oncol. 2022 Sep;126(3):588-598. doi: 10.1002/jso.26912. Epub 2022 May 6.
9
Predictive Indicators of Survival in Patients With Surgically Resected Lung Carcinoid Tumors at a Greek Medical Center.希腊某医疗中心手术切除的肺类癌肿瘤患者生存的预测指标
Cureus. 2020 Sep 7;12(9):e10300. doi: 10.7759/cureus.10300.
10
Wedge Resection Offers Similar Survival to Segmentectomy for Typical Carcinoid Tumors.楔形切除术为典型类癌肿瘤提供了与节段切除术相似的生存获益。
Semin Thorac Cardiovasc Surg. 2022 Spring;34(1):293-298. doi: 10.1053/j.semtcvs.2021.03.005. Epub 2021 Mar 10.

本文引用的文献

1
Incidence and Survival Outcomes in Patients with Lung Neuroendocrine Neoplasms in the United States.美国肺神经内分泌肿瘤患者的发病率和生存结果
Cancers (Basel). 2021 Apr 7;13(8):1753. doi: 10.3390/cancers13081753.
2
Wedge Resection Offers Similar Survival to Segmentectomy for Typical Carcinoid Tumors.楔形切除术为典型类癌肿瘤提供了与节段切除术相似的生存获益。
Semin Thorac Cardiovasc Surg. 2022 Spring;34(1):293-298. doi: 10.1053/j.semtcvs.2021.03.005. Epub 2021 Mar 10.
3
Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
肺和胸腺类癌:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Apr;32(4):439-451. doi: 10.1016/j.annonc.2021.01.003. Epub 2021 Jan 19.
4
Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines.英联邦神经内分泌肿瘤研究协作组和北美神经内分泌肿瘤学会肺神经内分泌肿瘤患者诊断和管理指南:对 2015 年欧洲神经内分泌肿瘤学会专家共识指南的国际协作认可和更新。
J Thorac Oncol. 2020 Oct;15(10):1577-1598. doi: 10.1016/j.jtho.2020.06.021. Epub 2020 Jul 11.
5
Role of Adjuvant Chemotherapy in Pulmonary Carcinoids: An NCDB Analysis.辅助化疗在肺类癌中的作用:NCDB 分析。
Anticancer Res. 2019 Dec;39(12):6835-6842. doi: 10.21873/anticanres.13900.
6
Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases.类癌淋巴结转移的发生率和预后意义。
Ann Thorac Surg. 2018 Oct;106(4):981-988. doi: 10.1016/j.athoracsur.2018.05.044. Epub 2018 Jun 15.
7
Extent of Resection and Lymph Node Assessment for Clinical Stage T1aN0M0 Typical Carcinoid Tumors.T1aN0M0期典型类癌肿瘤的切除范围及淋巴结评估
Ann Thorac Surg. 2018 Jan;105(1):207-213. doi: 10.1016/j.athoracsur.2017.07.049. Epub 2017 Nov 11.
8
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.2015 年世界卫生组织肺肿瘤分类:自 2004 年分类以来遗传、临床和放射学进展的影响。
J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630.
9
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.“类癌”百年之后:美国35825例神经内分泌肿瘤的流行病学及预后因素
J Clin Oncol. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377.